Tony Giordano

Company: NeuroTherapia Inc

Job title: President and Chief Executive Officer

Seminars:

Clinical Development Strategy for a Selective CB2 Agonist on Microglia for Alzheimer’s Disease 8:30 am

Presentation of a selective CB2 receptor agonist acting on microglial cells to improve neuronal functions in Alzheimer’s Disease Overview of ongoing and planned clinical trial development focusing on inflammatory effects Review strategies to ensure maintenance of avoiding CB1 targeting throughout clinical development NEW DATARead more

day: Conference Day One